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ABSTRACT
We have cloned the mouse IL2 gene and sequenced
2800 bp of 5' flanking DNA. Comparison to the
previously reported human sequence revealed
extensive identity ('- 86%) between the two genes from
+ 1 to - 580 with additional small islands of homology
further upstream. Proximal sites which have been
shown to be important in regulation of the human IL2
gene are well conserved in sequence and location.
Transfection experiments using hybrid gene constructs
containing varying lengths of the mouse 5' flanking
DNA linked to a CAT reporter gene have demonstrated
the presence of several novel positive and negative
regulatory elements. One negative regulatory region
lying between - 750 and -1000 consists primarily of
alternating purines and pyrimidines and is absent from
the human gene. The conserved region from - 321 and
- 578, an upstream segment from - 1219 to - 1332,
and another region of - 450 bp from - 1449 to - 1890,
which contained a well-conserved sequence of 60 bp,
were each associated with enhanced levels of
expression. We found no evidence for intragenic or
downstream enhancer elements in this gene. All the
elements identified affect only the magnitude of the
inducible response, for no region when deleted had the
effect of altering either the need for induction, the
kinetics of stimulation, or the cell-type specificity of
expression. Deletion studies suggest a strong
requirement for NFAT binding even in the presence of
extensive 5' flanking sequence. Therefore we conclude
that IL2 gene expression is controlled primarily through
a central TH1-specific signaling pathway, which acts
through proximal elements, while distal cis-elements
exert a secondary modulating effect.
INTRODUCTION
Perturbation of the antigen receptor/CD3 complex on resting T
cells initiates a variety of biochemical responses whose proximal
results include phospholipid hydrolysis, production of intracellular
second messengers, transmembrane calcium fluxes and activation
of protein kinase C1. These common, activation-specific events
result in the expression of a preprogrammed set of genes by the
EMBL accession no. X52618
responding cells, leading ultimately to proliferation and/or the
elaboration of effector function2.
The mechanisms by which cell-type-specific patterns of gene
expression are allocated to discrete subsets of cells are obviously
a fundamental aspect of T-cell development. To investigate the
nature of these mechanisms, we have focused on the regulation
of the murine IL2 gene. IL2 is subject to particularly stringent
control, both in cell-type specificity and in its requirements for
particular activating stimuli. The extreme transience of the
kinetics of IL2 expression, and the refractoriness of proliferating
normal T cells to IL2 induction, suggest that this gene is
negatively as well as positively regulated. In addition, various
T-cell subsets differ in the precise activation signals they require
for IL2 induction3'4. These considerations indicate that the
minimal mechanisms involved in activating IL2 transcription in
tumor cells may not fully account for the sophisticated
physiological control of this gene.
In this work, we have therefore characterized the sequences
and potential regulatory elements in the mouse IL2 gene in regions
extending considerably beyond the minimal 300 bp flanking
sequences previously shown to be required for expression. The
murine and human sequences appear to be strikingly well
conserved over a discrete region extending about 600 bp upstream
of the transcriptional start site. Additional islands of high sequence
identity appear up to at least 1700 bp upstream. This high degree
of conservation implies a functional role in regulation, which we
have tested here.
MATERIALS AND METHODS
Cloning the mouse IL2 gene
A BALB/c genomic library in the vector X Charon 4A was kindly
provided by Dr. L. Hood. The insert DNA consisted of equal
masses of sperm DNA that had been partially digested with Eco
RI or partially digested with a combination of Hae In and Alu
I followed by Eco RI linker addition5. The library was probed
with a nick-translated 470 bp Bgl II-Acc I mouse IL2 cDNA
fragment from pCD-mIL26 (generously provided by Dr. K.-I.
Arai, Institute of Molecular and Cellular Biology, Palo Alto, CA).
Positive plaques were isolated and the resulting phage purified
through two additional rounds of infection. Phage DNA was
prepared by standard plate lysate procedures7 and the Eco RI
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restriction fragment pattern was compared to the previously
published mouse IL2 map by DNA gel blot analysis using the
entire IL2 cDNA insert from pCD-mIL2 as a probe. Two clones,
XIL2 -9.1 and XIL2 -2.1, which contain the entire coding region
and flanking DNA were selected for further analysis.
Sequencing the IL2 5' flanking region
A 618 bp Rsa I-Pst I fragment extending from -578 to +40
relative to the start site of transcription was subcloned into the
Sma I-Pst I sites of pSP65 (Promega Biotec) and the sequence
determined according to Maxam and Gilbert8. A 2700 bp Eco
RI-Acc I fragment from XIL2-9.1 extending from -2800 to
-100 was subcloned into the Eco RI-Sma I sites of pGem7Zf(+)
(Promega) and the sequence determined by the dideoxy chain
termination method using the SequenaseTm 2.0 kit as directed
by the manufacturer (U.S. Biochemicals).
Plasmid construction-
A series of IL2-CAT hybrid genes was constructed in which
expression of the bacterial gene for chloramphenicol
acetyltransferase (CAT) is under the control of increasing
amounts of IL2 5' flanking DNA. These plasmids are designated
as pIL2 (-X) where X indicates the 5' terminal nucleotide,
relative to the transcriptional start site, that is included in the
construct. pIL2 (-2800) was constructed by first subcloning a
2.8 kb Eco RI-Pst I (-2800 to +40) fragment from XIL2-9.1
into the corresponding unique sites of pSP65, followed by
insertion of a 2.25 kb PstI fragment from pTK-CAT (gift of C.
Gorman and B. Howard, NIH9). This Pst I fragment contains
76 bp of HSV TK gene 5' untranslated DNA, the bacterial gene
for CAT, and SV40 downstream processing signals. pIL2
(-1890) was constructed in a similar manner but starting with
the 1.9 kb Eco RI-Pst I fragment from XIL2-2. 1 instead of the
2.8 kb fragment. pIL2 (-321) was made from pIL2 (-1890)
by first digesting with Bgl I followed by partial Xmn I digestion
and isolation of the largest fragment on a low-melt agarose gel.
This fragment was recircularized by ligation to an SmaI-BglI
fragment from pSP64. Plasmid pIL2 (-103) was generated from
pIL2 (-321) by digesting completely with Acc I, filling in with
Klenow polymerase and religating. pIL2 (-578) was made by
cloning a 618 bp Rsa I-Pst I fragment, extending from -578
to +40, into the Sma I-Pst I site of pSP65, followed by digestion
with PstI and insertion of the 2.25 kb Pst I CAT cassette described
above. pIL2 (-232) and pIL2 (-753) were made in the identical
manner beginning with, respectively, a 272 bp DdeI-PstI fragment
(-232 to +40) and a 793 bp Ssp I-PstI fragment (-753 to +40).
Plasmids pIL2 (-1449), pE12 (-1332), pIL2 (-1219), and pIL2
(-351) are deletions made by digesting pIL2 (-2800) with Stu
I (-2205) followed by addition of Bal 31 nuclease. Aliquots were
removed at 5, 10, and 15 min, treated briefly with the Klenow
fragment of E. coli polymerase I to generate flush ends, and
digested to completion with Bgl I. DNA in the desired size range
was isolated on a low-melt agarose gel and recircularized by
ligation to a Bgl I-Sma I fragment from pSP65. The exact extent
of the deletions was determined by sequencing.
pIL2 (-1890; ANFAT-1) was derived from pIL2 (-1890)
and pIL2 (-321). Both plasmids were digested to completion
with Xmn I and the following fragments were isolated on a low-
melt agarose gel: 1) a 4.5 kb fragment from pIL2 (-321) which
contained IL2 promoter sequences from -261 to +45, the CAT
gene and plasmid sequences; and 2) a 2.4 kb fragment from pIL2
sequences from -1890 to -322. These were ligated together
and the loss of the 60 bp Xmn I fragment confirmed by dideoxy
sequencing. Sequencing also revealed the loss of a C residue at
position -261. Thus, the ANFAT-1 deletion extends from -321
to -261, inclusive.
Plasmids containing intragenic or 3' flanking DNA were
constructed as follows. Genomic fragments (see Fig. IA)
designated A (350 bp Pvu II-Eco RI), B (2.2 kb Eco RI-Hind
III), C (1.8 kb Hind III), D(0.9 kb Hind III), E (l. kb Eco RI-
Asp 718), F (1.8 kb Asp 718-Eco RV), and G(2.0 kb Eco RV-
Eco RI) were cloned in both orientations into the unique Hind
III site in pIL2 (- 1890), either by blunt-end ligation (fragments
A, B, E, F, and G) or cohesive-end ligation (fragments C and
D). These were designated pIL2 (-1890) Y (+) or pIL2
(-1890) Y (-), where Y denotes the inserted fragment (A-G)
and +/- indicates, respectively, the sense and anti-sense
orientation of the inserted fragment with respect to the IL2-CAT
gene.
All plasmids were purified on CsCl-ethidium bromide density
gradients before use.
Drugs and reagents
The phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA)
(Sigma) was dissolved in Me2SO at a concentration of 10 Ag per
ml and the calcium ionophore A23187 (Calbiochem) was made
up in Me2SO to a final concentration of 0.37 mg per ml; both
were stored in small aliquots at -20°C.
Cell lines and DNA transfections
The human T-cell leukemia line Jurkat (kindly provided by Dr.
G. Crabtree, Stanford University) and the murine lines EL4.El,
NS-1, P388D1, and BW5147 were grown in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS), 50 AM
2-mercaptoethanol, 2 mM L-glutamine, and antibiotics. The
IL2-dependent lines HT-2, MTL2.8.2, and CTLL-2 were grown
in the same medium supplemented with 5% TPA-stimulated
EL4.EI cell supernatant as a source of growth factor. The 32D
cl 5 line was grown in Dulbecco's Modified Eagle Medium
(DMEM), which contained 10% FBS, 2 mM L-glutamine, and
20% WEHI-3B conditioned medium as a source of IL3. Ltk-
cells were grown in DMEM without IL3. DlO.G4.1 were
passaged every 10 days with antigen and antigen presenting cells
as described'0, except that we used 5% EL4.EI conditioned
medium instead of rat Con A supernatant as a source of growth
factors. Cells were maintained in logarithmic growth prior to
being transfected.
Transfection of hematopoietic cells with plasmid DNA was by
DEAE-dextran facilitation. Cells to be transfected were washed
in growth medium and counted. They were then rewashed in
serum-free DMEM containing 10 mM Hepes, pH 7 (hereafter
DME/H). Finally, the washed cells were resuspended to a density
of 1 x 107 per ml in a transfection cocktail consisting of
DME/H, 0.1 mM chloroquine, 250 jAg per ml DEAE-dextran(2 x 106 M.W.), and 10 Ag per ml supercoiled plasmid DNA.
The cells were put into loosely capped 17 x 100 mm round-bottom
polypropylene tubes (Falcon 2059) and placed in a 37°C/7%
CO2 incubator for 30 min (EL4.E1) or 60 min (Jurkat). The
tubes were swirled gently every 10 min to prevent extensive cell
clumping. Generally, 1-2 x 107 cells were transfected with each
plasmid in an experiment. After incubation in the transfection
cocktail, 6 ml of DME/H were added to each tube and the cells
(-1890) which contained the remainder of the plasmid and IL2 were pelleted at 500 x g in a room temperature centrifuge. Jurkat
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cells were then plated into two 60 mm tissue culture plates.
EL4.E1 cells were washed an additional time in 3 ml DME/H
containing 150 units per ml heparin (sodium salt; Sigma) to
reduce clumping before being plated. Approximately 24 hr post-
transfection, one plate of each pair received TPA and A23187
to final concentrations of 10 ng per ml and 37 ng per ml,
respectively. After an additional 18 hr of incubation, cells were
harvested for assay of CAT activity as described previously9
except that extracts were incubated for 5 hr.
All comparisons were based on multiple transfections using
at least two independent DNA preparations of each plasmid.
Transfections included pBR322 as a negative control and pRSV-
CAT as a positive standard for transfection efficiency. Relative
CAT activity was calculated by setting the pBR322 sample to
background and subtracting its cpm from the other samples. The
percent acetylation per 106 cell equivalents was then calculated
for each plasmid and normalized with respect to pIL2(-321),
which was arbitrarily set to 1.0. Results are presented as mean
+ S.E.M. While an internal standard for transfection efficiency
was not available during much of this work, the comparisons
presented in Figure 7 were based on a large number of repeated
experiments, in each of which all plasmids were transfected in
parallel, using the same transfection cocktail and target cells. In
each case, pRSV-CAT yielded 1-3% chloramphenicol
acetylation (in 5 hr) per 106 cells.
Ltk- cells were transfected by calcium phosphate
precipitation as described'1. Cells (8 x 105) were seeded in 100
mm tissue culture plates one day prior to transfection. Each plate
received 25 ptg of plasmid without added carrier DNA.
RNA extraction and gel blot analysis
Cytoplasmic RNA was extracted after 5 hr of stimulation with
TPA and A23187 as described, in the presence of 10 mM vanadyl
ribonucleoside complexes12. Approximately equalized masses of
RNA, usually 5-10 ,tg, were electrophoresed on denaturing 1%
agarose/formaldehyde gels and stained with acridine orange to
visualize the rRNA. The presence of residual vanadyl
ribonucleoside complexes led to some variation in the actual
amounts ofRNA loaded. The RNA was then blotted onto nylon
membranes (Nytran, Schleicher and Schuell) according to the
manufacturer's instructions. After baking at 80°C for 60 min
to fix the RNA, the filters were probed with random primed
cDNAs specific for human IL213 and mouse IL26 and ILA14. All
filters were also probed with a mouse a skeletal actin cDNA (N.
Davidson, Caltech, unpublished) to verify the integrity of the
RNA and to allow the signal to be normalized to the amounts
of RNA present in each lane. Hybridizations were for 20 hr at
420C in 5xSSPE, 50% formamide, 0.2% SDS, SxDenhardt's
and 10% dextran sulfate. Filters were washed three times for
1 min each at room temperature in 2xSSC, 0.2% SDS and
0.05% NaPP,, followed by two 30 min washes at 68°C in
0.2 x SSC, 0.1 % SDS, 0.05% NaPP,. They were then exposed
to film at -70°C with an intensifying screen.
RESULTS
Isolation of the mouse IL2 gene
We isolated phage containing the murine IL2 gene from a
BALB/c genomic library in X Charon 4A, using a 470 bp Bgl
II-Acc I nick-translated cDNA probe to identify six positive clones
representing four different genomic inserts (Fig. 1A). The
identities of the resulting clones were verified by comparison with
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Figure 1. Cloning the mouse IL2 gene and sequencing of its 5' flanking region.
(A) (i) Top lines (A-G) show the intragenic and 3' fragments that were tested
for the presence of transcriptional regulators. (ii) The organization of the mouse
IL2 gene is shown. Thin line denotes chromosome; thick boxes represent exons.
Arrow marks start site and direction of transcription. Letters under chromosome
represent restriction enzyme sites relevant to the constructions. R = EcoRI,
P = PvuII, H = HindU, As = Asp718 and RV = EcoRV. (iii) Thick lines
below exons 3 and 4 indicate the sequences included in the 3' cDNA probe used
in the library screen. (iv) Regions represented in genomic clones are diagrammed.
(B) Expanded view of exons 1 and 2 and 5' flanking DNA showing the sequencing
strategy employed. Letters designate restriction enzyme sites. R = EcoRI, Rs
= RsaI, A = AccI and Ps = PstI.
predictions from the genome organization and partial sequence
previously reported by Fuse et al. 15. These authors had shown
that, in the mouse, the IL2 gene resides on four contiguous EcoRI
fragments spanning 8.3 kb of DNA, as shown in Fig. lA. We
identified three genomic clones that contain at least 2 kb of 5'
flanking DNA in addition to the entire coding region. One of
the clones, XIL2-9. 1, contains the intact 3.3 kb genomic Eco RI
fragment upon which exons 1 and 2 reside, with at least 2.8 kb
of upstream sequence. Clones XIL2-2. 1 and XIL2-1 1. 1 appear
identical and possess a 2.4 kb Eco RI fragment that hybridizes
to a 5' IL2 cDNA probe (not shown). Their 5' termini are at
a HaellI site, modified with Eco RI linkers, 1.9 kb upstream of
the transcriptional start site. All of the clones isolated except
XIL2-9.1 also contain >7 kb of 3' flanking DNA.
We determined the sequence of the 2.8 kb of 5' flanking
sequence present on the 3.3 kb genomic Eco RI fragment, as
described in Materials and Methods. Figure lB shows the
sequencing strategy used. The major features of our murine
sequence (Fig. 2), in comparison to the human IL2 sequence,
are discussed in the following.
Comparison between murine and human sequences
A dot matrix comparison between the human'6 and mouse IL2
5' flanking sequences is shown in Fig. 3. There is extensive
sequence identity extending from -1 to -616, where it ends
abruptly, and also some scattered islands of similarity further
upstream. A direct sequence comparison of the mouse and human
5' flanking regions up to -580 (-585 in the human) is shown
in Fig. 4. The identity throughout this region is 86%, which is
similar to the degree of conservation between the proximal
upstream regions of other mouse and human lymphokine genes.
However, the length of the conserved upstream region is longer
r-
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-2800 GAATTCACAC TGGCCTCACA CCAGACTAAA CTGTAGCTTT
-2760 AATCCCATGA AAGATCAGGC AAAAGAAACT CTTGTGGGAG GTGGAGTTCT CAGTAGTTTG
-2700 CATGAGTGGA CCATGTAAGC AACAGGTGAC AGGTTCCCCG GGCAGCATCT CTAGGGTCTG
-2640 GGCCTGCCTT CACTTCTAGG AGCAGCTGGA ACAGCTAATA CTGAGCAGTA GAGCTCTGTG
-2580 GCTTATGACA CATGTGGTAG TCAGGCAGCG ACTGATTACA TCACCTCTCC AGCCAGAAAC
-2520 CCCAGCTGCT GTGTCAAGGA TGTTAAAAAT GGAAAGTGCA CCACAGCTGT TGGTAGCTTT
-2460 CTCCCCAAGC ATCTTAAGAA ACTGGGAGGC CAACCTTTGT AATGCTGCCA ATTATGCAAT
-2400 GCTCTGTAGG GGTGAACCTT GGCCCCAGGA ACTCATTCTA CAGGCTTTTA GAAACGCGGC
-2340 CATGTAAATT TCTCTAATGG AAACAGCTGG AGAAATAGAG ATGTTGAGCC CATGAGGACA
-2280 TCAAAGGCCC CACTGTGTGG AAAAGCCCCC ACACAGGAAA ATGTGTGGGC CTGACTCCTT
-2220 CCATTCTGGA AGGGGAGGCC TGAGTTGCTT GGGCTGGGAT GAGATGCTGA AGATCTGAGA
-2160 AGAGAGACAA GAGCATTGAG GCTGAGAGTT ATTAGGTAGA TGCCCCTCAC GATGGCATGC
-2100 TTAATCTGAA GGCACAGAAG GTGATGATGA CTAGGAGATT TGTCCCCATC CTGCTTTCCT
-2040 TCAGACATGC CAACAGGGCC ACTATGATAC CAGAAGTTGT CAAGCTTACT GCAAGATACA
-1980 TGCAGAGTTT TTTGTTGTTT TCTAGAATAC TGTCCAATGA TTGGAGAACT ATCCCAGAAC
*-1890
-1920 CATTCTCTGT TCTTTGTGAG AGACTTTAGG CCAACATTCC TTACATTGCT TAGTCTTCCT
-1860 GCTTTCACTA TTCCCCAGCA TCAAAATTAC ACTTAAAGTA ACTATCTCAA AACTCTTTAC
-1800 ATTGCCCAAC ATCCAACATT TCTAGGATGT TATCTGTCTC CATCCAAGGA TCAGGTCAAT
-1740 AGGAAGACAG ATGGTGTGAG AGTAGATTCT IGAGTCAGAA CATTCTAGTT TCGAATCTTC
--1710
-1680 ACCCTACCCT TTACTGGCAA AAT GATTTATCTA ATCTACCCAC
-1645^
-1620 AGTGTGCATG TAGCAGTCAA AGACAACTTG TGGAGTCAGT GAGAACTGAC TTCCACCTTT
-1560 ATGTAAGTTC AGGGATCAGA GAGCAAGGTT TGTATAGCAA GCCCCTTAGT CATCTCATCA
-1500 CCCTACATICC TCAGTTTTCA AATCTAC GTGGTAGGT GGCTTG
^-1492 -1466^ --1451 -1440^
-1440 AATCTGTGTA TTTGCACATA
--1420 -1400-1400
'-1332
-1380 T CT AG TA CAAGTTAT TAGAAATGGG GACACCACAG
-1377- --1373
-1354^
-1320 GCAAGCTCCC TAAGAAAGAC CCCGTCTCTA CCAGTTGATT TGGAACTATG TTCCTACTCC
*-1219
-1260 ATCACGCAGC CAGTGTACTA CACGGAGGAT AAGGAATCCA ATGTATCCTA TTCAGGTGAC
-1200 CCACTGAGAA CACGTGGGAT AGTCCCTAGC TATTACT GCCCA GGTACTTTTA
^-1162
-1140 GAACCC AAATCTACTG AATTAGGGGG AAGAAGGTTG GCAAGATGCC TCAGTGGTAA
-1134^
-1080 AGGCTAGGTA GAGGCTAGTA GCAGAGGTAG GCACACAGAC TGGATGACTT TTGTGTTTAG
-1020 ATTTCTGAGT CACACAAGGT GACAGGAGAG AAGTTACTAG CAAGAGTTGG TCTCTGACCT
-960 CCACAGGTGT ACTGTGGCAC ACACACACAC ACACACTM AATACTGTG CACAAATGCA
-900 TGTACACATA CATACACACA TGCATACATG fCACACACACAQTCATATA C-C-CGC^AA
-840 TAAACATGCT CACACACACA TACATGT CA CATACTCATA CACACATGAA
*-753
-780 CACATGTGTG TGTACACACG TGAAAATATT TTTTAAAAAT GAAAGTGCAA CTAGAGACAT
-720 ATAAAATAAC ACCAACATCC TTAGATGCAA CCCTTCCTGA GAATTTGTTG GACATCATAC
-660 TCT*TTAAA AAGCATAATA AACATCKFL CiTTACACA AAAAGTTA AATTAA*TT
^-656 -629- -616 -604^
'-578
-600 AAAACAACAA CGACAAAATA GTACCTCAAG CTCAACAAGC ATTTTAGGTG TCCTTAGCTT
-540 ACTATTTCTC TGGCTAACTG TATGAAGCCA TCTATCACCC TGTGTGCAAT TAGCTCATTG
-480 TGTAGATAAG AAGGTAAAAC CATCTTGAAA CAGGAAACCA ATATCCTTCC TGTCTAATCA
-420 ACAAATCTAA AAGATTTATT CTTTTCATCT ATCTCCTCTT GCGTTTGTCC ACCACAACAG
*-351 *-321
-360 GCTGCTTACA GGTTCAGGAT GGTTTTGACA AAGAGAACAT TTTCATGAGT TACTTTTGTG
-300 TCTCCACCCC AAAGAGGAAA ATTTGTTTCA TACAGAAGGC GTTCATTGTA TGAATTAAAA
*-2 32
-240 CTGCCACCTA AGTGTGGGCT AACCCGACCA AGAGGGATTT CACCTAAATC CATTCAGTCA
-180 GTGTATGGGG GTTTAAAGAA ATTCCAGAGA GTCATCAGAA GAGGAAAAAC AAAGGTAATG
*- 103
-120 CTTTCTGCCA CACAGGTAGA CTCTTTGAAA ATATGTGTAA TATGTAAAAC ATCGTGACAC
-60 CCCCATATTA TTTTTCCAGC ATTAACAGTA TAAATTGCCT CCCATGCTGA AGAGCTGCCT
+1 ATCACCCTTG CTAATCACTC CTCACAGTGA CCTCAAGTCC TGCAG
Figure 2. Sequence of the mouse IL2 gene 5' flanking region from -2800 to +45. Sequence was determined by both chemical degradation and dideoxy chain
termination methods. Regions upstream of -580 that show homology to the human IL2 gene are boxed (see Fig. 4). Underlined and overlined regions show stretches
of poly d(CA) and poly d(GT), respectively. Asterisks indicate the 5' termini of the IL2 sequences in the constructs diagrammed in Fig. 6.
in the IL2 gene than in IL3, IL6, and GM-CSF17-19. As for of up to 48 residues (Fig. 2). The alternating Pu-Py tracts may
other lymphokine genes, this degree of flanking sequence have been introduced into the murine gene, or deleted from the
conservation is considerably greater than that of the coding human gene, en bloc, because where mouse-human sequence
regions of the two genes. Such strong evidence of evolutionary similarities resume further upstream, they are out of register.
pressure against sequence divergence suggests that sequences The murine sequence is usually present at a position about 250
throughout this region play a role in DNA-protein interactions bp further from the RNA cap site than its human counterpart
required for IL2 gene regulation. (see Figs. 3 and 5). Of interest is the presence of two contiguous
The sequence similarity terminates abruptly about 100 bp from 7 bp direct repeats of the sequence 5'-ACACATA-3' between
the border of a striking feature of the murine sequence, namely -746 and -733 of the human IL2 gene, suggesting the possible
the block of alternating purines and pyrimidines between -759 loss of a longer alternating Pu-Py stretch by recombinational
and -960. There is nothing in the human gene which corresponds excision.
to this murine sequence. On the coding strand, poly(dC-dA) Figure 5 lists the additional promoter-distal regions of sequence
predominates with interspersed islands of poly(dG-dT), in runs similarity identified by the dot-matrix comparison of the murine
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Figure 3. Dot matrix comparison of mouse IL2 upstream region from -2800
to +45 and human sequence from - 1370 to +45 using the Pustell program from
the Mac-Vector DNA analysis software package (IBI). The hash level was 6 and
the window size was 25 and the minimum positive score was set at 65 %. Human
sequence was from Holbrook'6, with the start site of transcription moved 8 bp
to the 3' direction in accord with Taniguchi42 and Devos et al.43.
and human genes. Some of these matches are impressive; 28/30
identical base pairs with one gap (between -1645 and -1674
in the murine gene); 15/16 identical (-1695 to -1710); 24/27
identical (between -1466 and -1492); and 19 identical in a
contiguous run of 21 (between -1400 and -1420). These do
not represent obvious repetitions of motifs found in the more
proximal regions, nor do the conserved sequences include
recognizable binding sites for the DNA-binding proteins
considered in the next section. Their functional significance will
be discussed in a later section.
Candidate binding sites for transcription factors
Several DNA binding proteins have been shown to footprint over
the region from -1 to -279 in the human IL2 gene20'21 and
these protected regions have been shown by genetic analysis to
play a role in its inducible expression20'22'23. The regions
protected by two of these proteins, NF-IL2A (Oct-i) and
NFAT-1, are indicated in Fig. 4. The proximal NF-IL2A site
is perfectly conserved between the two genes, while the distal
sites differ at 7 out of 39 nucleotides. The binding site for
NFAT-1, a protein restricted to activated T cells24 whose
appearance precedes IL2 gene transcription, is also conserved
well, though not perfectly, between mouse and human. This is
not surprising in view of the fact that nuclear extracts from
activated EL4.E1 cells contain a protein which has similar
properties to NFAT-1 in a gel retardation assay24. Binding sites
for NF-xB and AP-1-like factors in the human gene25-27 are
conserved in both sequence and position in the mouse 5' flanking
region.
A computer-assisted search of the IL2 5' region identified
several potential binding sites for known regulatory proteins in
the promoter-distal flanking regions of the murine IL-2 gene.
These identifications are provisional because they are based solely
upon homology to published consensus sequences. We could
not locate consensus motifs for T-cell receptor decamer
(AGTGATGTCA, at a level of 80%)28, Spl (GGGCGG, at a
level of 85%) or the cAMP response element CREB
(TGACGTCA, at a level of >75% matching). The failure to
identify consensus motifs of course does not exclude other binding
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Figure 4. Comparison of mouse and human IL2 immediate upstream regions
from -580 to +45. Dashes indicate identity, and gaps were added by visual
inspection to maximize matches. Indicated on the figure are binding sites for
NFAT-1, NF-xB, NF-IL2A and AP-1 (see text). Other proteins footprint over
this region but have not been identified25. Overlines indicate binding sites for
proteins demonstrated to interact with the mouse or human IL2 promoter. The
extent of each binding site shown is from published consensus sites for AP-1
and NF-xB264, from deletion analysis for NFAT-1 and the proximal NF-IL2A
site20, and from footprint analysis for the distal NF-IL2A site20. For sites that
were determined by several methods, the minimum size of the site is shown.
sites for any of these factors. However, we did locate four
glucocorticoid response element (GRE) core motifs
(TGTTCT)29 at -1913, -1704, -1194, and -327. The GRE
at -1704 falls within an extended region of similarity between
the mouse and human IL2 genes (Figs. 3 and 4B). Normally,
the signals inducing IL2 transcription can be mimicked by the
combination of calcium ionophore and TPA30 . The proteins
AP-1 and AP-3 are involved in TPA-inducible gene responses,
and consensus binding sites have been proposed for both. In
addition to the probable AP-1 binding sites at - 153 and at
-18525,27, there are two more potential sites further upstream
at -1515 and -1015. Three possible AP-3 sites are present at
-2708, -2492, and -2264.
Far upstream elements modulate 1L2 expresion in THl-type
lymphomas
Extensive analysis of the human IL2 gene promoter has revealed
numerous regions between -60 and -361 which, when deleted,
reduce the level of inducible expression of a linked reporter gene
following transfection into the Jurkat and EL4 T-cell
lines20'22'23'26. At least five regions have been implicated thus
in activation. There is no evidence, however, that this catalogue
of positive elements is complete. Furthermore, there has been
no test of the functional roles of negative regulatory sequences
in the maintenance of strict activation and/or tissue specificity
of this gene. Because the upstream conservation between mouse
and human IL2 genes suggests a functional role for sequences
lying 5' to -300, we constructed a series of IL2-CAT plasmids
in which the bacterial gene for chloramphenicol acetyltransferase
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GGAGTCAGAACATTCTAGTTTCGAATC TTCACCCTACCCTTTACTGGCAATAAGG CTGAGTAACCT
-T-------CT----A----C--- T- -G---C---------------G------G----
-1360 -1295
-1492 -1466
CCTCAGTTTTCAAATCTACAAAATGGG
-----------T-----G------A--
-1267
-1451 -1440
AGGCTTATGTTA
--A-----A---
-1217 -1206
-1420
-1241
-1400
TTTTCTCCCTTTCTATGTACC
-------T--------A----
-1175 -1155
-1400
*CAGTTTAGTGAAAA
-1373
CCCAGGATGTTTTAGATGGTAGATAAAT
-____-
-- A------ - -
-821 -790
-1377 -1354
TAAATGTCTGCATAAAGACTAGAC
--G--0----- TT -------C----
-1137
-1162
-1114
-1134
TCAGAGTG CCCAGGTACTTT TAGGATAAA
---T ----T------- GA---AG-------
-830
-656
-629
TTTAAAAAGCATAATAAACATCAAGACA
--
--GT----
-659 -630
-616 -604
ATGTTAAATTAAA
--T----------
-611 -599
Figure 5. Comparison of nine mouse and human similarity regions located
upstream of -580. Top line is mouse sequence. Gaps have been introduced by
inspection to maximize similarity. Numbers above and below the sequences indicate
their position relative to the transcriptional start sites of the respective genes.
is under the control of the mouse IL2 gene promoter. To minimize
non-IL2 regulatory sequences that might elevate basal levels of
expression nonspecifically, no heterologous promoter or enhancer
sequences were included. The structures of these chimeric
molecules, containing between 103 bp and 2800 bp of 5' flanking
IL2 DNA, are diagrammed in Fig. 6.
The smallest construct, pIL2 (-103) CAT, contains only the
promoter-proximal NF-IL2A enhancer element. The pIL2
(-232) construct includes, in addition, three putative sites for
inducible activation factors: NF-xB (at -206) and two proposed
AP-1 sites (at -185 and -153). All sites known to be 'essential'
are included in the pIL2 (-321) and longer constructs2.
To test for a role of promoter-distal elements in controlling
the magnitude of inducible IL2 expression, this series of plasmids
was introduced into Jurkat and EL4.El cells, and the resulting
CAT activity determined after 18 hr of stimulation with A23187
and TPA (Fig. 6). In all cases, the plasmids were transfected
into the same cell population in parallel, with our shortest
expressible construct [pIL2(-321)] serving as a normalization
standard for the resulting levels of CAT activity. The combined
results of a series of analyses are presented schematically in
Fig. 7.
With the exception of pIL2 (- 103) and pIL2 (-232), all the
IL2-CAT plasmids yielded easily detectable amounts of CAT
activity in extracts from transfected cells following stimulation
(Fig. 7). There was no detectable CAT activity in any case unless
the cells were stimulated, in accordance with the fact that
transcription of the IL2 gene is linked tightly to cell
activation2'31. The failure of pIL2 (-103) to be expressed under
any conditions indicates that this fragment lacks intrinsic promoter
function in the absence of enhancing elements between -103
and - 321. Expression was detectable with pIL2( -232), but this
was at least an order of magnitude less than from pIL2(-321).
Thus, the NF-xB, Oct-l and AP-1 candidate sites are not
sufficient for efficient induction in these cells.
There were several effects from increasing the amount of IL2
flanking DNA beyond -321. While both positive and negative
effects were observed, in general they were small in magnitude
when assayed in the EL4.E1 or Jurkat tumor cells. In these
constructs, the upstream elements were not separated from
powerful proximal enhancer elements which may have obscured
their function. The description that follows is provided
nevertheless, in view of the possibility that some of these sites
could play a stronger role in normal cells with more stringent
regulation of IL2.
First, the increase in 5' flanking DNA from -321 to -578
was correlated with a reproducible increase in CAT activity, in
both cell lines. This suggests that additional positive regulatory
elements are located between -321 and -578 in the murine
gene, in agreement with the evidence for stringent sequence
conservation. The effects of adding these sequences had not been
noted previously in studies with the human gene22.
Second, there appears to be a weak negative regulatory region
lying somewhere between -578 and -1219. In both cell lines
examined, CAT activity was reproducibly about two fold lower
with pIL2 (-1219) than with pIL2 (-578). The pIL2 (-1219)
plasmid encompasses the block of alternating purine-pyrimidine
residues that is not found in the human 5' flanking region. To
test whether the poly d(CA) tract or other sequences in this region
act as negative regulators, we cloned a 260 bp HinFI-SspI
fragment containing the poly d(CA) region upstream of the IL2
promoter sequences in pIL2 (-103) and pIL2 (-321). These
constructs were then transfected into EL4.El cells in parallel with
the unmodified parental plasmids. That this region lacks intrinsic
enhancing activity in EL4.El is shown in Table I. The presence
of one or two copies of the d(CA) tract was unable to impart
transcriptional activity to pIL2 (- 103). Furthermore, when one
to three copies of this element are inserted upstream of the
expressible (-321) construct, the resulting plasmids showed a
lower level of CAT activity than did the unmodified parental
plasmids. Thus, rather than possessing positive enhancing
activity, the poly d(CA) region could account for the lower level
of expression seen with pIL2 (-1219). To test alternative sites
for the negative element(s) in this region, we examined two
additional constructs, pIL2 (-753) and pIL2 (-1219; A- 1002
to -579). Results (not shown) revealed that both pIL2 (-753)
and pIL2 (- 1219; A-1002 to -579) were expressed as well
as pIL2 (-578), thus implicating the poly d(CA) tract as most
likely to account for the negative effect on IL2 promoter function.
Third, there was evidence for two novel positive regulatory
elements further upstream. Their effects were detected more
clearly in the conspecific EL4.El line than in the human Jurkat
cells, which tend to express the longer constructs poorly in
general (see below). The negative effect of sequences between
-1219 and -578 was reproducibly found to be reversed by
including additional 5' IL2 sequences as little as 113 bp further
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Figure 6. (Left) pIL2-CAT constructs. The number in parentheses refers to the 5' terminal nucleotide located in the plasmid. All IL2 sequences terminate downstream
at +45 in the 5' untranslated region. Thick line, IL2 5' sequence; black box, poly(dC-dA) tract; open box, CAT gene; stippled box, SV40 sequences containing
small t intron and polyadenylation sites. Vector is pSP65 (not shown). Arrow indicates start site of transcription. H indicates location of unique HindIll site in pIL2
(-1890) used in construction of plasmids with intragenic and 3' genomic sequences. (Right) Representative CAT assay of extracts from Jurkat cells transfected
with each of the indicated constructs. Unacetylated chloramphenicol and its monoacetylated derivatives are indicated with (C) and (CA), respectively.- = uninduced;
+ = 18 hr stimulation with TPA + A23187.
upstream, suggesting the presence of a positive element in this
interval. Both pIL2 (-1332) and pIL2 (-1449) showed higher
levels of expression than pIL2 (-1219) (Fig. 7). At least one
other possible positive regulator of IL2 gene expression lies
further upstream. Inclusion of the sequences between -1449 and
-1890 reproducibly resulted in the highest level of IL2-promoted
CAT activity achieved in EL4.E1 cells. Note that this region
includes the highly conserved sequences between -1466 and
-1492, between - 1645 and -1673, and between -1694 and
-1710, as described above. An additional increase to -2800
had a modest negative effect in EL4.E1, which was more
substantial in human Jurkat cells.
In general, the positive or negative effects on expression of
each increment of 5' flanking sequence were observed both in
murine EL4.E1 cells and in human Jurkat cells. However, as
shown in Fig. 7, the two lines differ in their relative strengths
of reporter gene expression from the IL2(-578)-CAT and
IL2(-1890)-CAT constructs, with EL4.E1 showing considerably
higher expression from the longer constructs. Whether this
reflects a cell-type-specific (or species-specific) positive
regulatory element, or alternatively a systematic difference in
the utilization of longer fragments of exogenous DNA, is not
presently resolved.
Absence of 3' and intragenic enhancers
Transcriptional enhancers have been discovered 3' to the mouse
T-cell receptor Cf2 locus32 and CD36 gene33 and the human
CD2 gene34. We therefore tested the possibility that additional
transcriptional regulatory sequences reside within or 3' to the
IL2 gene by subcloning different fragments of genomic DNA
(Fig. lA) into pIL2 (-1890) as described in Methods. In these
constructs, the genomic fragments were inserted 0.6 kb
downstream of the two SV40 derived polyadenylation sites, and
therefore were not included in the IL2/CAT transcription unit.
In this way, 5.0 kb of 3' flanking DNA and all but 100 bp of
intragenic DNA were tested. All of these constructs were
expressed at a lower level than the parent plasmid from which
they were derived (Table II). Clearly there are no positive
regulatory elements in these regions that can act in a position-
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Figure 7. Pooled CAT assay data from transfected Jurkat (A) and EL4.E1 (B)
cells. Relative CAT activity calculated as in Materials and Methods. Numbers
in bars are the number of times that a given plasmid was tested in parallel with
pIL2 (-321) CAT as a reference standard. Only results from 18 hr stimulated
cells are shown. Results are presented as mean S.E.M.
independent way. These results do not, however, identify
sequence-specific negative regulatory regions, because the degree
of inhibition seemed primarily related to the length of the inserted
DNA. While the relative reductions seen in CAT activity greatly
exceed the decreases in the molar concentration of plasmid DNA
in the transfection protocol, it remains possible that nonspecific
mechanisms were responsible for limiting expression. The more
dramatic negative effect of B (second intron) may, however,
indicate that some sequences limiting IL2 expression are indeed
located outside of the 5' flanking region.
A
4
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Table I. The polyd(CA) * Ipolyd(GT) tract lacks transcriptional enhancing activity
in ELA.E1 cells
Relative
Plasmid Inserta CAT activityb
pIL2 (-103) 0
1 x CA(+) 0
1xCA(-) 0
2xCA 0
pIL2 (-321) 1.0
1 x CA (+) 1.0±0.3
1 x CA (-) 0.78±0.01
2 x CA 0.48±0.08
3 x CA 0.42±0.01
aThe number of copies of the 260 bp HinFI-SspI polyd(CA) fragment is
indicated. (+) or (-) indicates the orientation of this fragment relative to its normal
location in the IL2 upstream region. The orientation was not determined for
plasmids containing multiple copies.
Plasmids were transfected into EL4.E1 cells along with pBR322 as a negative
control. Relative CAT activity was determined as indicated in Table III after 18
hr stimulation with 10 ng/ml TPA + 37 ng/ml A23187. Results are the mean
range of two experiments.
Control of tissue-specific IL2 expression is mediated through
the 5' flanking DNA by a THl-specific signalling pathway
Normally, IL2 gene transcription appears to be restricted to
activated THI cells, even though these cells share a common
precursor with all hematopoietic cells. To test the roles of IL2
regulatory sequences in maintaining cell-type specificity, the
series of pIL2-CAT plasmids was transfected into a variety of
hematopoietic and non-hematopoietic cell lines by DEAE-dextran
facilitation, as shown in Table IH. The panel included other T-
cell types, such as TH2 cells and CTLs, in addition to non-T
cells. To ensure delivery of an activation signal we used agonists
of the universal phosphoinositide pathway, namely the calcium
ionophore A23187 and the phorbol ester TPA. After an 18 hr
stimulation with TPA + A23187, the cells were harvested and
assayed for the presence of CAT.
None of the plasmids was expressed in any cell line tested
except EL4.E1 and Jurkat, although only the results for pIL2
(-1890) are shown here. This lack of expression by other cell
lines is not due to their refractivity to transfection or to an inability
to respond to TPA + A23187. All the cells listed express easily
detectable amounts of CAT protein when transfected with a
control plasmid, pRSV-CAT, and several of them (32D c15,
S49.1, our subline of BW5147, and others) possess an activation
pathway capable of further elevating expression from the RSV
LTR upon stimulation. The successful stimulation of the HT-2,
32D cl 5, and D10.G4. 1 lines was demonstrated by their synthesis
of endogenous IL4 RNA under these conditions (Fig. 8 and data
not shown). Table Ill shows that even the combination of
transfectability and inducibility in these cell lines is not sufficient
to permit expression from any IL2 promoter fragment, even when
introduced as naked DNA. Thus, cell-type specific expression
of IL2 appears to depend upon a signalling response specific to
TOl-type lymphomas.
Subordination of distal modulator elements to a common
activation pathway
In general the different extents of 5' flanking sequence affected
the magnitude but not the kinetics of CAT expression from the
IL2-CAT constructs after induction. Comparison of the relative
levels of CAT activity expressed at 6 hr, 9 hr, and 24 hr of
Table H. Absence of intragenic or 3' enhancer elements in the mouse IL2 gene
Relative
Plasmid Insert Size (kb) CAT activitya
pIL2 (-1890) 1.0
A(+) 0.35 0.54±0.12
B(+) 2.3 0.23±0.08
C(+) 1.8 0.40±0.17
D(+) 0.9 0.50±0.11
E(+) 1.1 0.43±0.08
E(-) 1.1 0.53±0.12
F(+) 1.8 0.71±0.27
F(-) 1.8 0.49±0.16
G(+) 2.0 0.48±0.18
G(-) 2.0 0.53±0.20
aCAT activity in extracts of cells stimulated for 18 hr with TPA + A23187 was
determined as in Table III except that values were normalized with respect to
p1L2 (-1890). Results are given as mean E range oftwo experiments for fragments
A-D and three experiments for fragments E-G.
induction showed indistinguishable kinetics with any of the
plasmids (data not shown). Thus, the positive and negative effects
on expression appear to be kinetically subordinate to a common
time course of stimulation.
To test whether the stimulatory effects of the upstream elements
could obviate the requirement for the NFAT-1 site, we
constructed a derivative ofpIL2(- 1890) from which the NFAT-1
site was specifically excised. This construct, pIL2(- 1890;
ANFAT-1), was transfected into EL4.E1 cells in parallel with
the parental pIL2(-1890) and the pIL2(-321) constructs. As
shown in Fig. 9, upon stimulation the pIL2(-1890; ANFAT-1)
construct was expressed at severely reduced levels even in
comparison with the minimal pIL2(-321) construct. Thus, no
signaling mediators generated in these tumor cells were capable
of activating the upstream sequences independently of NFAT-1.
The particular severity of this reduction of activity, in comparison
with the milder effects of NFAT-1 site deletions in shorter human
IL2 constructs20'23 may further indicate a necessary role for the
conserved sequence from -301 to -322 (Fig. 4), which is also
removed from the ANFAT construct.
DISCUSSION
Structure of the murine IL2 5' flanking region
In order to understand the molecular basis for the restricted
expression of the murine IL2 gene we have cloned the gene and
determined the nucleotide sequence of the 5' flanking region.
Our upstream sequence extends to -2800 relative to the start
site of transcription; this is 2300 bp further upstream than
sequences previously reported15. This region showed no
extended homology to any other murine lymphokine gene.
Comparison of this sequence to that previously determined for
the human IL2 genel6 revealed extensive similarity from -1 to
-616 with the regions between -1 and -580 displaying 86%
identity throughout their length. Thus, the evolutionarily
conserved sequence in the IL2 5' flanking region extends - 350
bp beyond the sequences previously reported to be required for
maximal induction of the human IL2 promoter20'22'23, with
patches of similarity resuming further upstream. The extensive
conservation suggests a role for multiple regulatory sequence
elements in the relatively complex control of IL2 gene expression.
The sequence conservation between -1 and -616 is
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Figure 8. Gel blot analysis of cytoplasmic RNA extracted from induced and noninduced hematopoietic cell lines. Total cytoplasmic RNA was fractionated on denaturing
agarose/formaldehyde gels, blotted, and hybridized with the indicated probes as described in Methods. Data presented are from sequential hybridizations of the different
probes with the same filter. - = uninduced; + = induction with TPA + A23187. Cell lines are (1) EL4.E1, (2) BW5147, (3) HT-2, (4) P388D1, (5) WEHI -3B,
(6) 32 D cl 5, (7) NS-1. Note that our subline of BW5147 is not inducible for IL2, in contrast to others in the literature45.
remarkable less for its degree than for its length. In general,
comparisons of the immediate upstream regions of other
lymphoid-specific genes show regions of similar conservation
between murine and human. The extent of these homologous
regions, however, tends to be on the order of 300 bp17-19. For
example, the mouse and human IL2Rcx gene upstream regions
contain only 42 mismatches in the first 300 bp (86% similarity),
but contain 51 mismatches in the next 92 bp (45% similarity;
data and numbering scheme from ref. 35).
In addition to overall sequence conservation, the human and
mouse IL2 promoters also contain binding sites for identified
trans-acting factors located in the same order and in the same
place. It is likely that other factors, as yet unidentified, interact
with sequences upstream of -300 since there must be selective
pressure to keep these sequences so similar. The high degree of
homology in the regions between known sites suggests that some
factors may bind very close to one another or even overlap in
their DNA recognition specificity. The possible inclusion of
negative regulatory sites could explain some of the internal
deletion results of Williams et al-23, in which a smaller internal
deletion from -361 to -335 in the human IL2 promoter reduced
expression much more severely than a larger deletion from -361
to -292. Postulating contiguous and/or overlapping sites can also
explain why the identified protein binding sites have not moved
around relative to one another since the divergence of mice and
humans as they have in other genes (e.g., metallothionein-I36).
Deletion analysis of the mouse IL2 upstream region suggests
a net positive role for the conserved sequences between -351
and -578, although these are not required for expression of the
murine or the human20'22'23 gene. Transfection experiments
utilizing IL2 promoter-CAT constructs demonstrated that an
increase in 5' DNA from -351 to -578 was correlated with
an increase in inducible CAT activity. This is in accord with the
results of Williams et al. 23 showing that certain deletions in this
region could dramatically reduce expression from the IL2
promoter even when the binding sites for NFAT-1, NF-xB, and
Oct-l and AP-1 were intact. That sequences upstream of -321
could play a role in regulating IL2 gene expression is further
supported by experiments of Nabel et al.37 using various
upstream regions of the human IL2 gene as probes in gel mobility
shift assays.
Table HI. pIL2-CAT expression is cell-type specific and dependent on both cell-
type and gene-specific inductive signals
Endogenous pRSV-CAT pIL2(-1890)
Cell mRNAa activityb Fold CAT activityb
line Cell type IL2 1L4 - + induction - +
NS- I B-cell - - 0.33 0.33 1.0 0 0
32D cl 5 Pre-mast cell - + 3.8 14.3 3.8 0 0
P388D1 Macrophage - - 0 0.1 - 0 0
HT-2 TH2 - + 0.55 3.3 6.0 0 0
DIO.G4.1 TH2 - + N.D.c 0.28 N.D. 0 0
BW5147 Thymoma - - 0.7 4.2 6.0 0 0
MTL2.8.2 CIL - - 9.9 9.3 0.9 0 0
CTLL-2 CiL - - 9.7 19.3 2.0 0 0
Ltk- Fibroblast - - 17 22 1.3 0 0
EL4.El Thymoma + + 0.35 3.4 10 0 0.42
Jurkat THI + N.D. 8.7 12.8 1.5 0 4.1
aCytoplasmic RNA was extracted after 5 hr stimulation with 10 ng/ml TPA +
37 ng/ml A23187 and analyzed as described in Materials and Methods.
bCAT activity is presented as% acetylation per 1 x 106 cell equivalents in a 5
hr assay, except for Ltk- extracts, which were assayed for 30 min.
- = unstimulated; + = 18 hr stimulation with 10 ng/ml TPA + 37 ng/ml
A23187, except for Dl0.G4.1 cells, which were cultured at 2x IO per ml for
45 h with 6.7 x 105 mitomycin C-treated spleen cells and 100 mg conalbumin
per Al. 0 = < 0.05.
cNot done.
Further upstream, the murine and human sequences diverge,
but regulatory effects of specific sequences are still seen. A
potential positive element or elements can be correlated with a
region where several islands of excellent mouse-human similarity
reappear (between -1440 and -1890). Another likely positive
element occurs in the region between -1219 and - 1332. On
the other hand, a striking aspect of the mouse 1L2 upstream region
is the poly d(CA) region from -1000 to -750, apparently
associated with a negative regulatory effect. Stretches of
alternating purines and pyrimidines are found upstream of a
number of murine lymphokine genes (e.g., IL6, GM-CSF)17,18
and in their large introns (e.g., HA, IL6)17'38, but apparently not
in their human counterparts. The regulatory implications of this
difference are not clear. Poly d(GT) - Id(CA) is able to assume
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Figure 9. Defective expression of pIL2 (- 1890;ANFAT). The figure shows a
representative CAT assay of ELA.E1 cells transfected with the indicated constructs
as described in Materials and Methods. Similar results were obtained in three
separate experiments. - = uninduced; + = induction with TPA + A23187.
In this experiment stimulation was for 5 hr. In another experiment (not shown),
pIL2 (-1890; ANFAT) gave 4% as much activity as pIL2 (-1890) at 18 hr
of stimulation.
a Z-DNA configuration39, and d(GT) Id(AC)30_130 has been
reported to show weak transcriptional enhancing activity in
fibroblasts in conjunction with a truncated SV40 early
promoter4°. Because the poly d(CA) tract is correlated with
lower levels of expression from the IL2 promoter, it is possible
that such tracts have either enhancing or silencing effects,
depending on the promoter.
Role of regulatory sequences in control of 1L2 gene expression
The critical question is the relationship between the regulatory
properties of these novel upstream elements and those of the
promoter-proximal elements described before2. There are three
general possibilities. First, the upstream elements may be
enhancers (and partial silencers) in their own right, normally
cooperating with downstream inducible elements but capable of
autonomous action. Second, the upstream elements may represent
inducible enhancers and silencers, interdependent with the
proximal elements but conferring altered sensitivity to particular
inductive stimuli or altered cell-type specificity. Third, the
upstream elements may be subordinate to the proximal elements,
capable of modulating levels of expression but not of activating
expression autonomously. Our results argue against the first two
models and support the third.
An important result of our investigations was the inability to
segregate any of the determinants of induction-dependence or
pharmacological sensitivity (in Novak, Chen, and Rothenberg,
and Novak and Rothenberg, mss. submitted for publication), from
expression per se. By contrast, Serfling et al.25 have suggested
that when IL2 upstream sequences are combined with a
heterologous promoter, the resulting expression is somewhat less
induction-dependent when shorter ( - 300 bp) IL2 sequences are
used than with longer ( 2000 bp) ones, possibly due to
artefactual read-through transcription by RNA polymerases41. In
our experiments using the natural IL2 promoter with its regulatory
sequences, it is striking that all constructs from pIL2 (-321) to
pIL2 (-2800) were induced or inhibited in parallel, with
indistinguishable kinetics, although to different maximal levels.
These results strongly suggest that the overall progress of IL2
promoter induction is governed by a single rate-limiting
mechanism, to which all the specific positive and negative
upstream sites are subordinate.
The poor activity of the pIL2(-232) and pIL2(-1890;
ANFAT-1) constructs suggest that NFAT binding may be one
required component of this mechanism in EL4.E1 cells. Thus,
the distal regulatory elements we have described appear to be
quantitative modulators of expression, rather than targets of
autonomous activation processes. The mechanism of their action
remains unknown. In principle, they may act as sites for specific
DNA protein interaction or as regions which alter DNA topology
or nucleosome phasing. It is important to note, however, that
even NFAT binding is unlikely to be sufficient to activate IL2
gene transcription in the absence of NF-xB-like, Oct-I-like, and
AP-l-like factors20'26 (Novak et al., submitted for publication).
It is not yet clear whether the upstream sequences might be able
to compensate for a deficit in one of these other positive
regulatory factors.
A final conclusion is that the activation pathway responsible
for IL2 gene induction appears to be confined to THl-type cells.
The results in Table III are clearly inconsistent with a single
universal set of phosphoinositide pathway response factors in T
cells, since many T-ceil lines could not express any IL2 promoter
construct, even when introduced as naked DNA. The
nonexpressors included cell lines capable of expressing IL4 RNA
in response to stimulation, showing that the difference between
'THI' and 'TH2' cell types does not reside exclusively in the
methylation status or accessibility of their endogenous IL2 genes
in chromatin. Elsewhere, we show that even within the same
clonal cell population, the two lymphokine RNAs show
differential susceptibility to cAMP (Novak and Rothenberg,
submitted for publication). The implication is that IL2 and IL4,
which has a broader cell-type distribution than IL2, are induced
through distinguishable sets of transcriptional regulators. The
identification of key differences between these sets will allow
the developmental relationship between THI and TH2 cells to be
explicated in molecular terms.
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